COVID-19 Global & China Viral Vectors Market Research by Company, Type & Application 2017-2027

Table of Contents
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Retroviral Vectors
1.1.2.2 Lentiviral Vectors
1.1.2.3 Adenoviral Vectors
1.1.2.4 Herpes Simplex Virus Vectors
1.1.2.5 Chimeric Viral Vectors
1.1.2.6 Others
1.1.3 Market by Application
1.1.3.1 Cancers
1.1.3.2 Inherited Disorders
1.1.3.3 Viral Infections
1.1.3.4 Others
1.2 Global & China Market Size & Forecast
1.2.1 Global Market (2017-2021 & 2021-2027)
1.2.2 China Market (2017-2021 & 2021-2027)
2 Global & China Market by Company
2.1 Global Sales by Company
2.2 China Sales by Company
3 Global & China Market by Type
3.1 Global Sales by Product Type
3.2 China Sales by Product Type
4 Global & China Market by Application
4.1 Global Sales by Application
4.2 China Sales by Application
5 China Trade
5.1 Export Overview
5.2 Import Overview
6 Key Companies List
6.1 BioReliance
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (2017-2021) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Cobra Biologics
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (2017-2021) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Oxford BioMedica
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (2017-2021) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 UniQure
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (2017-2021) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 FinVector
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (2017-2021) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 MolMed
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (2017-2021) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 MassBiologics
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (2017-2021) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Richter-Helm
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (2017-2021) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 FUJIFILM Diosynth Biotechnologies
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (2017-2021) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Lonza
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (2017-2021) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Aldevron
6.11.1 Company Information
6.11.2 Product Specifications
6.11.3 Business Data (2017-2021) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.12 Eurogentec
6.12.1 Company Information
6.12.2 Product Specifications
6.12.3 Business Data (2017-2021) ( Sales Revenue, Cost and Margin)
6.13 Cell and Gene Therapy Catapult
6.13.1 Company Information
6.13.2 Product Specifications
6.13.3 Business Data (2017-2021) ( Sales Revenue, Cost and Margin)
6.14 Biovian
6.14.1 Company Information
6.14.2 Product Specifications
6.14.3 Business Data (2017-2021) ( Sales Revenue, Cost and Margin)
6.15 Brammer Bio
6.15.1 Company Information
6.15.2 Product Specifications
6.15.3 Business Data (2017-2021) ( Sales Revenue, Cost and Margin)
6.16 VGXI
6.16.1 Company Information
6.16.2 Product Specifications
6.16.3 Business Data (2017-2021) ( Sales Revenue, Cost and Margin)
6.17 PlasmidFactory
6.17.1 Company Information
6.17.2 Product Specifications
6.17.3 Business Data (2017-2021) ( Sales Revenue, Cost and Margin)
7 Industry Upstream
7.1 Industry Chain
7.2 Upstream Overview
8 Policies & Market Environment
8.1 Policies
8.1.1 Major Regions Policies
8.1.2 Policies in China
8.2 Market Environment
8.2.1 Porter's Five Forces
8.2.2 Impact of COVID-19
9 Research Conclusion

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.